Our study demonstrates that TSC and decitabine synergistically affect the viability of lung cancer cell line A549 and urothelial bladder cancer cell line J82 by caspase 3/7-mediated apoptosis. This evidence concerns the gene CASP3 and bladder transitional cell carcinoma.